Please wait while we open this resource.
K
Clinical reviews
NEW DRUG THERAPIES FOR HYPERTENSION
INSERM CIC1418, Hôpital Européen Georges Pompidou, APHP, Université Paris Cité, University of Washington
PDF202615 pages1.2 MB
Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain low due to factors like low treatment adherence and therapeutic inertia. New drug therapies, including small interfering RNA agents and aldosterone synthase inhibitors, are being developed to improve hypertension management. The document emphasizes the importance of balancing the benefits of these innovations with considerations of safety, cost, and equitable access to reduce the burden of cardiovascular and chronic kidney disease.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology
PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology
OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology
CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology
The Athlete’s ECG
Same clinical topic · Cardiology
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology
Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology
Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology
INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology